Cogent Biosciences Ransomware Claim by N0n (Nov 2026)
Unverified dark web claim. This report is based on a post observed on a dark web forum. Yazoul Security has not independently verified the authenticity of this claim.
Leak Site Screenshot
Screenshot captured at time of discovery. Image blurred to protect victim PII.
Claim Summary
The ransomware group tracked as N0n has purportedly listed Cogent Biosciences, Inc., a US-based clinical-stage oncology biopharmaceutical company, on its dark web leak site. According to the threat actor, the alleged attack occurred on November 6, 2026. The group claims to have exfiltrated data from what it describes as an “open and closed claims analytics environment,” allegedly containing millions of patient claim rows with patient, claim, and provider identifiers alongside full diagnosis code detail. The listing is marked “[NOT PAID - EXPOSED],” suggesting the actor claims a ransom demand went unmet. No data volume was disclosed. None of these claims have been independently verified, and the listing should be treated as an unconfirmed assertion at this time.
Threat Actor Profile
N0n is a relatively obscure ransomware operation with little to no public research footprint. Open-source intelligence provides no confirmed victim count, no documented toolset, and no established tactics, techniques, and procedures (TTPs) attributable to this group. This absence of a track record is itself a significant credibility concern. Established ransomware brands typically accumulate documented tooling, negotiation patterns, and victim histories that analysts can reference. N0n’s lack of verifiable history means its claims cannot be corroborated against prior behavior. Organizations should treat the group as unproven and potentially opportunistic, possibly a rebrand, a low-volume operation, or even a persona exaggerating capabilities. Because no YARA rules or detection signatures are publicly available for this actor, defenders should rely on generic ransomware detection guidance rather than actor-specific indicators.
Alleged Data Exposure
According to the threat actor, the purportedly exposed data centers on a claims analytics environment. The group alleges the dataset includes patient, claim, and provider identifiers together with full diagnosis code detail, and describes the data as “actively growing today.” If accurate, such a dataset would be highly sensitive, combining protected health information (PHI) with financial claims records. However, the claim is unsubstantiated. The actor provided no sample data, no volume estimate, and no verifiable proof within the listing text reviewed. Ransomware groups frequently overstate the scope and sensitivity of stolen data to increase pressure on victims. Yazoul Security has not reviewed, obtained, or validated any of the alleged data, and none is reproduced here.
Potential Impact
If the claim were substantiated, the potential impact could be severe given the healthcare context. A dataset containing patient and provider identifiers plus diagnosis codes could implicate HIPAA breach notification obligations, state privacy laws, and potential regulatory scrutiny. Affected individuals could face risks of medical identity theft or insurance fraud. Business operations, partner trust, and litigation exposure could also be affected. That said, these are hypothetical consequences contingent on the claim being true. Cogent Biosciences has not confirmed any breach in the information reviewed. Readers should avoid drawing conclusions about the company or its patients until independent verification occurs.
What to Watch For
- Official statements from Cogent Biosciences or regulatory disclosures that confirm or deny the claim.
- Any notification filed with HHS or state attorneys general, which would lend credibility.
- Corroborating evidence from independent security researchers or incident response firms.
- Changes to the leak site listing, including removal, which sometimes indicates negotiation or retraction.
- For healthcare defenders: review claims-analytics system access controls, monitor for anomalous data egress, and validate backup integrity. Generic ransomware detection remains advisable given the lack of actor-specific signatures.
Disclaimer
This report is based solely on an unverified claim posted to a ransomware group’s leak site. Nothing in this article has been independently verified by Yazoul Security. The allegations are attributed to the threat actor and should not be treated as fact. Ransomware groups routinely exaggerate or fabricate claims to pressure victims. No personally identifiable information, data samples, credentials, or access details are included. Readers should await official confirmation before acting on any information presented here.
Never miss a threat intelligence alert
Get real-time security alerts delivered to your preferred platform.
Related Claims
Dompé Farmaceutici S.p.A. — N0n
Delta Dental of Missouri — N0n
Arthritis Center of Riverside — N0n
Asisken Asistencia Médica S.A. — N0n